Impact of non-alcoholic fatty liver disease on late cardiovascular events and death in Chronic Obstructive Pulmonary Disease
D. Viglino (Grenoble, France), A. Plazanet (Grenoble, France), S. Bailly (Grenoble, France), M. Benmerad (Grenoble, France), I. Jullian-Desayes (Grenoble, France), R. Tamisier (Grenoble, France), V. Leroy (Grenoble, France), J. Zarski (Grenoble, France), M. Maignan (Grenoble, France), M. Joyeux-Faure (Grenoble, France), J. Pépin (Grenoble, France)
Source: International Congress 2018 – COPD and extrapulmonary comorbidities
Session: COPD and extrapulmonary comorbidities
Session type: Thematic Poster
Number: 4038
Disease area: Airway diseases
Rating:
You must login to grade this presentation.
Share or cite this content
Citations should be made in the following way:
D. Viglino (Grenoble, France), A. Plazanet (Grenoble, France), S. Bailly (Grenoble, France), M. Benmerad (Grenoble, France), I. Jullian-Desayes (Grenoble, France), R. Tamisier (Grenoble, France), V. Leroy (Grenoble, France), J. Zarski (Grenoble, France), M. Maignan (Grenoble, France), M. Joyeux-Faure (Grenoble, France), J. Pépin (Grenoble, France). Impact of non-alcoholic fatty liver disease on late cardiovascular events and death in Chronic Obstructive Pulmonary Disease. 4038
You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
Related content which might interest you:
Related content which might interest you: